Agilent
Avatar Pharmaceuticals
CombinatoRx
Foundation Medicine
GenomeQuest
Harvard-MIT HST
Hypnion
Idera Pharmaceuticals
Massachusetts Biotechnology Council
Neuco
Synta Pharmaceuticals
TheraGenetics
Verenium
Veridocs
Veristat
The second annual report for CombinatoRx, reflects the company’s accelerated pipeline developed with proprietary technology.
print | web site
2007 ANNUAL REPORT
2008 ANNUAL REPORT
CLINICAL TRIALS MARKETING CAMPAIGN
Campaign in multiple languages for CRX-102 in Osteoarthritis and Rheumatoid Arthritis.
WEB SITE
Click to view this site
